VCU Massey Cancer Center

Menu

Clinical news

New patient-centered program at VCU Massey Cancer Center raises the bar for pancreatic cancer care

VCU Massey Cancer Center recently opened its Pancreas and Biliary Neoplasm Program for patients like Tuppince. The program is the first of its kind in the Richmond area, and it aims to reduce treatment delays and improve outcomes through a multi-disciplinary, patient-centered approach.

Continue reading →

Massey physician-researcher honored with health care service award

VCU Massey Cancer Center physician-researcher Todd Adams, M.D., was recently awarded the 2016 Sherry Kohlenberg Healthcare Service Award from the Virginia Breast Cancer Foundation (VBCF) for his “commitment to the fight against breast cancer”.

Adams is a radiation oncologist and member of the Developmental Therapeutics research program at Massey as well as an assistant professor in the Department of Radiation Oncology at VCU School of Medicine.

The award was named after a former healthcare administrator and co-founder of the VBCF who died from breast cancer in 1993. The award is given by the VBCF to recognize health care workers in Virginia who “exhibit a deep and abiding commitment to the fight against breast cancer.”

Continue reading →

Massey physician-researcher helps develop and lead national breast cancer studies

VCU Massey Cancer Center physician-researcher Charles Geyer, M.D., co-developed and co-led two important national breast cancer clinical trials that were recently presented at the American Society of Clinical Oncology’s annual meeting in Chicago. One study was presented in the “Best of ASCO” Program, which presents the scientific and educational highlights of the meeting. 

Continue reading →

Novel combination therapy developed at Massey shows strong response in patients with advanced solid tumors

A phase 1 clinical trial testing a novel combination therapy developed by scientists at VCU Massey Cancer Center slowed the growth of cancer in the majority of trial participants, which were patients with advanced solid tumors. Approximately 61 percent of these patients experienced some degree of tumor growth delay, with multiple partial responses and one complete response. A phase 2 study testing the same combination of the drugs sorafenib and pemetrexed in patients with recurrent or metastatic triple negative breast cancer is now open at Massey. 

Continue reading →

Massey Physicians named Richmond Magazine’s Top Docs 2016

VCU Massey Cancer Center physicians again were recognized in Richmond Magazine’s annual list of “Top Docs.” Featured in the magazine’s April 2016 issue, the list includes 31 doctors from varied specialties who provide oncology-related care to Massey’s patients, including 10 who care for pediatric patients at the Children’s Hospital of Richmond at VCU. The selections were the result of a survey that asked Richmond-area physicians who they would recommend in a range of specialties.

Continue reading →